Catalyst Wire Dossier Catalyst Wire Dossier

Benralizumab (Fasenra)

benralizumab · AstraZeneca
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Benralizumab (Fasenra), covering 2025-01-14 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy

See pricing